Showing posts with label drugs. Show all posts
Showing posts with label drugs. Show all posts

January 31, 2013

Patients Resist Digital Doctoring

Modern Physician reports that "The pull-down menus, alerts and point-of-care information contained in computerized clinical decision-support systems [CDSS] can distract physicians from their face-to-face encounters and leave patients feeling ignored and dissatisfied with their care." This comes from a study at the University of Missouri at Columbia that evaluated patient perceptions of doctors using digital diagnostic tools.

"Get over it!" is the first thing that comes to mind. Would you begrudge your mechanic hooking up your car to the diagnostic computer and scrutinizing the bars and gauges and charts on the screen? The physician has to use tools, just like everyone else, to achieve peak performance in treating patients. Personally, I'd rather see the back of his head researching my complaint to take advantage of every inspiration and precaution, than to look at a smiling face telling me "Shucks, I don't know, let's try some drugs!"

The time has come for us as patients to embrace the new technology, just as we insist that our doctors do the best job possible in our behalf, and to get used to some changes in the doctor-patient relationship.

April 24, 2012

Hurry Up, Sunshine


Senators Chuck Grassly (R-IA) and Herb Kohl (D-WI), authors of the Physician Payments Sunshine Act, are pushing for CMS to get its final implementation rule out the door. Once the rule is published, the process of collecting data on financial transactions between doctors and industry vendors can start. Six months after CMS missed the October 1, 2011 statutory deadline, the senators expressed their displeasure with the agency's slow movement.

After missing the implementation date, CMS again missed a March 31, 2012 start date for the 1,150+ drug, device, biologics and medical supplies manufacturers to report all "transfers of value" given to physicians and teaching hospitals.

The Sunshine Act, as it is nicknamed, is designed to bring transparency to physician interactions with revenue sources that may unduly influence decisions regarding patient care. While such sources as manufacturers' payments for research are vital to healthcare technology development, patients should know when (and what for) large sums of money are attached to their doctors' treatment decisions.

Proposed implementation, published December 19, is available online.